Olympus says it agreed to pay $92 million to settle a pair of civil lawsuits brought over the 2001 accounting scandal that nearly brought the company down.
Olympus issues an urgent safety advisory on cleaning the endoscopes implicated in lethal 'superbug' outbreaks across the country.
Olympus faces another lawsuit over a 'superbug' infection allegedly caused by 1 of its endoscopes.
A patient infected with a drug-resistant 'superbug' at a Los Angeles hospital sues Olympus, the maker of the endoscope that allegedly caused the infection.
(Reuters) — A 76-year-old man infected with a drug-resistant "superbug" at a Los Angeles hospital has sued the manufacturer of a medical device that allegedly caused the illness in the 5th lawsuit related to the bacterial outbreak at the facility, his attorney said yesterday.
The FDA's gastroenterology & urology devices advisory panel is slated to meet in May to review the recent, deadly outbreak of hospital-acquired infections from endoscopy procedures.
(Reuters) — The FDA said an advisory panel is slated to discuss the transmission of "superbug" infections through endoscopy procedures in U.S. hospitals.
Here's a look at some of the top regulatory stories for medical device companies this week: Olympus sold 'superbug' scopes without our clearance; FDA clears 1 Hospira plant, flags another; GI Dynamics plunges 50% after FDA halts trial; Sunshine Heart stops trial enrollment after patient deaths; Petition accuses Bayer's Conceptus of altering Essure trial data
The widow of a patient who died after being infected with E. coli by an Olympus endoscope is suing the hospital and the company for wrongful death.